Herseltpharma
0892.542.332 · rovalta.com · 09/11/2026
Herseltpharma
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOHerseltpharma is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Herselt. It employs on average 3,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0892.542.332
- Incorporation
- 04/10/2007
- Legal form
- Private limited company
- Registered office
- Dorp 50
2230 Herselt · FlandreSee on map - Contributed capital
- 63 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,7 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 18 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 821,5 k € | +45.9% | 563,1 k € | +11.1% | 506,8 k € | +12.9% | 449,1 k € | +16.3% | 386,1 k € |
| EBITDA | 577,2 k € | +62.3% | 355,7 k € | +9.0% | 326,4 k € | +20.3% | 271,3 k € | +27.7% | 212,5 k € |
| Operating result | 443,3 k € | +111% | 210,5 k € | -11.2% | 237,1 k € | +41.0% | 168,1 k € | +54.1% | 109,1 k € |
| Net result | 268,8 k € | +180% | 95,9 k € | -26.3% | 130,2 k € | +53.2% | 85 k € | +108% | 40,8 k € |
| Balance sheet | |||||||||
| Equity | 920 k € | +16.8% | 788 k € | +13.9% | 692,1 k € | +12.1% | 617,6 k € | +16.0% | 532,6 k € |
| Total assets | 1,3 M € | -14.1% | 1,5 M € | -2.8% | 1,6 M € | +4.4% | 1,5 M € | -0.4% | 1,5 M € |
| Cash | 110,9 k € | +2.9% | 107,8 k € | -47.5% | 205,5 k € | +121% | 93 k € | +22.3% | 76 k € |
| Debts | 391,9 k € | -45.9% | 724,4 k € | -16.8% | 870,2 k € | -1.1% | 879,9 k € | -9.3% | 969,7 k € |
| Other | |||||||||
| Workforce | 3,7 ETP | 0.0% | 3,7 ETP | +5.7% | 3,5 ETP | -2.8% | 3,6 ETP | 0.0% | 3,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Kathleen Gielis | DirectorManager2018 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Dominique Torfs | Manager01/01/2008 → 2015 accounts | ||
Patrick Van Mechelen | Manager04/10/2007 → 2010 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/06/2026 | 04/08/2025 | 12/07/2024 | 17/07/2023 | 14/07/2022 | 20/07/2021 |
| General meeting | 15/06/2026 | 16/06/2025 | 17/06/2024 | 19/06/2023 | 20/06/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 15/06/2026 | 16/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 16/06/2025 | 04/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 17/06/2024 | 12/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 19/06/2023 | 17/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 20/06/2022 | 14/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/06/2021 | 20/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 15/06/2020 | 13/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 17/06/2019 | 02/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 18/06/2018 | 09/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 19/06/2017 | 06/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/06/2016 | 09/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 15/06/2015 | 17/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 16/06/2014 | 25/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 17/06/2013 | 30/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 18/06/2012 | 27/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 20/06/2011 | 11/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 21/06/2010 | 28/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 15/06/2009 | 12/07/2009 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Kathleen Gielis | DirectorManager2018 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Dominique Torfs | Manager01/01/2008 → 2015 accounts | ||
Patrick Van Mechelen | Manager04/10/2007 → 2010 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring24/05/2024RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring01/03/2024KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates15/01/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Registered office02/02/2018BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates16/09/2016ontslag en benoeming zaakvoerders
- Capital / shares25/03/2014KAPITAALVERHOGING (ART 537 WIB 92) - STATUTENWIJZIGING(EN).
- Mandates11/05/2012ONTSLAGEN - BENOEMINGEN
- Other12/10/2007Oprichting, statuten en benoeming zaakvoerder(s).
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Dorp 50, 2230 HerseltCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00163986 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| HerseltpharmaCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00163986 |
Events
- 2025Annual accounts 2025268,8 k €↑
- 2024Annual accounts 202495,9 k €↓
- 2023Annual accounts 2023130,2 k €↑
- 2022Annual accounts 202285 k €↑
- 2021Annual accounts 202140,8 k €↓
- 2020Annual accounts 202069,9 k €↑
- 2019Annual accounts 201966,8 k €↑
- 2018Annual accounts 201855,7 k €↑
- 2017Annual accounts 201724,1 k €↓
- 2016Annual accounts 201650,1 k €↑
- 2015Annual accounts 201546,9 k €↑
- 2014Annual accounts 201432,8 k €↓
- 2013Annual accounts 201334,1 k €↑
- 2012Annual accounts 201232,2 k €↓
- 2011Annual accounts 201135,8 k €↑
- 2010Annual accounts 201019 k €↑
- 2009Annual accounts 20099,2 k €↑
- 2008Annual accounts 20081,6 k €
- 04/10/2007IncorporationPrivate limited company